Pharmacokinetic properties of a single intramuscular dose of buprenorphine in African grey parrots (Psittacus erithacus erithacus)

Journal of Avian Medicine and Surgery

Volumn 18, Issue 4, 2004, Pages 224-228

  Paul Murphy, Joanne ^a   Hess, Jennifer C ^a   Fialkowski, James P ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

African grey parrot; Analgesia; Avian; Buprenorphine; Noncompartmental pharmacokinetics; Opioid; Psittacus erithacus

Indexed keywords

BUPRENORPHINE;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; NONHUMAN; PARROT; SINGLE DRUG DOSE;

ANIMALIA; AVES; ERITHACUS; PSITTACIDAE; PSITTACUS ERITHACUS;

EID: 10344248246     PISSN: 10826742     EISSN: None     Source Type: Journal    
DOI: 10.1647/2001-039     Document Type: Article

References (27)

1. Barrett DA, Simpson J, Rutter N, et al. The pharmacokinetics and physiological effects of buprenor phine infusion in premature neonates. Br J Clin Pharmacol. 1993;36:215-219.
2. Bullingham RES, McQuay HJ, Moore A, Bennett MRD. Buprenorphine kinetics. Clin Pharmacol Ther. 1980;28:667-672.
3. Lloyd-Jones JG, Robinson P, Henson R, et al. Plasma concentration and disposition of buprenorphine after intravenous and intramuscular doses to baboons. Eur J Drug Metab Pharmacokinet. 1980;5:233-239.
4. Livingston A, Nolan A, Waterman A. The relationship between analgesia induced by, and plasma concentration of, buprenorphine in the sheep. Br J Pharmacol. 1986;88:363.
5. Waterman AE, Livingston A, Amin A. Further studies on the antinociceptive activity and respiratory effects of buprenorphine in sheep. J Vet Pharmacol Ther. 1991;14:230-234.
6. Hussain A, Kimura R, Huang CH, Kashihara T. Nasal absorption of naloxone and buprenorphine in rats. Int J Pharmacol. 1984;21:233-237.
7. Usha PTA, Rajagopalan MK. Comparative study of the analgesic effects of buprenorphine, pentazocine and xylazine in mice. J Vet Anim Sci. 1990;21:53-54.
8. Pontani RB, Vadlamani NL, Misra AL. Disposition in the rat of buprenorphine administered parenterally and as a subcutaneous implant. Xenobiotica. 1985;15:287-297.
9. Brewster D, Humphrey MJ, Mcleavy MA. The systemic bioavailability of buprenorphine by various routes of administration. J Pharm Pharmacol. 1981;33:500-506.
10. Bullingham RES, McQuay HJ, Dwyer MC, Moore RA. Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis. Br J Clin Pharmacol. 1981;12:117-122.
11. Taylor PM, Robertson SA, Dixon MJ, et al. Morphine, pethidine and buprenorphine disposition in the cat. J Vet Pharmacol Ther. 2001;24:391-398.
12. Blogg SL, Townsend PP, Butler PJ, Taylor EW. A method of anesthesia and post-operative care for experimental procedures in avian species. Anim Technol. 1998;49:101-109.
13. Gentle MJ, Hocking PM, Bernard R, Dunn LN. Evaluation of intraarticular opioid analgesia for the relief of articular pain in the domestic fowl. Pharmacol Biochem Behav. 1999;63:339-343.
14. Ranee MJ. Animal and molecular pharmacology of mixed agonist-antagonist drugs. Br J Clin Pharmacol. 1979;7:281S-286S.
15. Wood PL, Sanschagrin D, Richard JW, Thakur M. Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment. J Pharmacol Exp Ther. 1983;226:545-550.
16. Leander JD. Opioid agonist and antagonist behavioural effects of buprenorphine. Br J Pharmacol. 1983;78:607-615.
17. Villiger JW, Taylor KM. Buprenorphine: high-affinity binding to dorsal spinal cord. J Neurochem. 1981;38:1771-1773.
18. Ho ST, Wang JJ, Ho W, Hu OYD. Determination of buprenorphine by high-performance liquid chromatography with fluorescence detection: application to human and rabbit pharmacokinetic studies. J Chromatogr. 1991;570:339-350.
19. Cone EJ, Gorodetzky CW, Yousefnejad D, et al. The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos. 1984;12:577-581.
20. Ohtani M, Kotaki H, Sawada Y, Iga T. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther. 1995;272:505-510.
21. Paul-Murphy JR, Brunson DB, Miletic V. A technique for evaluating analgesia in conscious perching birds. Am J Vet Res. 1999;60:1213-1217.
22. Paul-Murphy JR, Brunson DB, Miletic V. Analgesic effects of butorphanol and buprenorphine in conscious African grey parrots (Psittacus erithacus enthacus and Psittacus erithacus timneh). Am J Vet Res. 1999;60:1218-1221.
23. Rowland M, Tozer TN. Clinical Pharmacokinetics: Concepts and Applications. 3rd ed. Baltimore, MD: Williams and Wilkins; 1995.
24. Watson PJ, McQuay HJ, Bullingham RE, et al. Single-dose comparison of buprenorphine 0.3 and 0.6 mg given after operation: clinical effects and plasma concentrations. Br J Anaesth. 1982;54:37-43.
25. Mansour A, Khachaturian H, Lewis M, et al. Anatomy of CNS opioid receptors. Trends Neurosci. 1988;11:308-314.
26. Walsh SL, Preston KL, Stitzer ML, et al. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther. 1994;55:569-580.
27. Hoppes S, Flammer K, Hoersch K, et al. Disposition and analgesic effects of fentanyl in white cockatoos (Cacatua alba). J Avian Med Surg. 2003;17:124-130.